+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Connected Drug Delivery Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302911
The global market for Connected Drug Delivery Devices was estimated at US$5.8 Billion in 2023 and is projected to reach US$22.9 Billion by 2030, growing at a CAGR of 21.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Connected Drug Delivery Devices Market - Key Trends & Drivers Summarized

What Are Connected Drug Delivery Devices, and Why Are They Transforming Healthcare?

Connected drug delivery devices are medical devices equipped with sensors and connectivity features that allow for the monitoring and management of drug administration. These devices include smart inhalers, insulin pens, wearable injectors, and auto-injectors that transmit real-time usage data to healthcare providers, offering insights into patient adherence and treatment efficacy. Connected drug delivery devices improve medication compliance, provide personalized dosage guidance, and enable remote patient monitoring, making them especially valuable in chronic disease management, where adherence to treatment is crucial for health outcomes. By facilitating seamless communication between patients and healthcare providers, these devices are transforming healthcare delivery, ensuring that patients receive the most effective, personalized care.

The significance of connected drug delivery devices lies in their ability to enhance patient engagement and adherence to prescribed regimens, which is vital in managing chronic conditions like diabetes, asthma, and rheumatoid arthritis. The data collected by these devices offers healthcare providers actionable insights into treatment patterns and patient behavior, enabling proactive intervention when adherence issues arise. Additionally, the real-time feedback provided by connected devices helps patients manage their medications more effectively, reducing the risk of missed doses and potential complications. As healthcare systems increasingly focus on patient-centered, data-driven care, connected drug delivery devices play a crucial role in improving treatment outcomes.

How Are Technological Advancements Enhancing Connected Drug Delivery Devices?

Technological advancements are rapidly improving the capabilities and applications of connected drug delivery devices, making them more precise, patient-friendly, and versatile. Integration of Bluetooth, Wi-Fi, and near-field communication (NFC) technologies allows for seamless data transfer from the device to mobile apps and cloud platforms, where data can be analyzed and accessed by healthcare providers in real time. AI and machine learning algorithms are also transforming connected drug delivery devices, enabling personalized medication schedules and predicting adherence patterns based on patient behavior, enhancing the overall treatment efficacy.

Advances in wearable technology have led to the development of more comfortable and discreet devices, such as smart insulin pumps and wearable injectors, that can deliver medication with minimal disruption to daily life. Furthermore, mobile app integration allows patients to receive reminders, dosage tracking, and educational resources, which promotes adherence and empowers patients to manage their conditions actively. Enhanced battery life and miniaturization have made these devices more portable and user-friendly, catering to the needs of active and mobile patients. Together, these technological advancements make connected drug delivery devices an integral part of modern healthcare, improving patient adherence, convenience, and treatment success.

What Are the Key Applications of Connected Drug Delivery Devices Across Patient Care?

Connected drug delivery devices are widely used across a range of chronic disease management applications, where consistent medication adherence is essential. In diabetes management, smart insulin pens and continuous glucose monitors (CGMs) allow patients to administer and track insulin doses accurately, providing data that supports personalized dosing and reduces the risk of complications. For respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), connected inhalers offer reminders and feedback on inhaler usage, helping patients adhere to prescribed regimens and enabling providers to monitor control of the condition remotely.

In the field of oncology, wearable injectors allow for controlled delivery of chemotherapy drugs, reducing the need for frequent hospital visits and enabling patients to manage their treatment at home. Connected auto-injectors are used in rheumatoid arthritis treatment, ensuring patients receive their medications as prescribed and providing data that healthcare providers can use to optimize treatment plans. In clinical trials, connected drug delivery devices improve data accuracy by capturing precise dosing information, reducing reliance on patient self-reporting and enhancing trial integrity. These applications underscore the versatility of connected drug delivery devices in supporting various aspects of patient care, from disease management to clinical research.

What Factors Are Driving Growth in the Connected Drug Delivery Devices Market?

The growth in the connected drug delivery devices market is driven by several factors, including the rise of chronic diseases, technological advancements in connected healthcare, and increasing emphasis on patient adherence. With the prevalence of chronic conditions like diabetes, asthma, and cardiovascular disease on the rise, connected drug delivery devices are in high demand for their role in improving adherence and ensuring effective treatment outcomes. Technological advancements, such as AI, mobile app integration, and real-time data analytics, are enhancing the capabilities of these devices, making them more user-friendly and effective in managing patient care remotely.

The growing acceptance of telemedicine and remote patient monitoring has further boosted adoption, as connected drug delivery devices allow healthcare providers to track adherence and intervene when necessary, reducing hospital visits and improving patient engagement. Increased focus on personalized medicine has also spurred demand for devices that offer customizable dosing schedules and real-time monitoring, aligning with the trend toward tailored treatment solutions.

Moreover, pharmaceutical companies and healthcare providers are recognizing the benefits of connected drug delivery devices in clinical trials, where they improve data accuracy and patient compliance. Together, these factors are driving the expansion of the connected drug delivery devices market, supporting its role in enhancing healthcare delivery and patient outcomes in an increasingly digital healthcare landscape.

Scope of the Study

The report analyzes the Connected Drug Delivery Devices market, presented in terms of market value (US$ Million). The analysis covers the key segments and geographic regions outlined below.

Segments

Offering (Standalone Components & Software, Integrated Devices); Administration Route (Parenteral Administration, Inhalational Administration); Application (Diabetes Management Application, COPD Application, Asthma Application, Other Applications)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Diabetes Management Application segment, which is expected to reach US$11.5 Billion by 2030 with a CAGR of a 22.2%. The COPD Application segment is also set to grow at 20.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $1.7 Billion in 2023, and China, forecasted to grow at an impressive 20.7% CAGR to reach $3.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Connected Drug Delivery Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Connected Drug Delivery Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Connected Drug Delivery Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Connected Drug Delivery Devices Market such as Adherium Limited, Aterica, Biocorp, FindAir, Merck KGaA and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Global Connected Drug Delivery Devices Market report include:

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Connected Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Drives Demand for Connected Drug Delivery Devices That Enable Remote Patient Monitoring
  • Growth in Home Healthcare Expands Market for Connected Drug Delivery Devices That Offer Self-Administration and Real-Time Feedback
  • Rising Focus on Personalized Medicine Propels Demand for Connected Devices That Provide Customizable Dosing and Monitoring
  • Advancements in IoT Technology Strengthen Business Case for Connected Drug Delivery Devices with Real-Time Data Sharing
  • Growing Demand for Patient Adherence Solutions Drives Adoption of Connected Drug Delivery Devices with Reminder and Tracking Features
  • Expansion of Digital Health Solutions Supports Market for Connected Devices That Integrate with Mobile Apps and Health Portals
  • Increasing Focus on Reducing Healthcare Costs Drives Demand for Connected Drug Delivery Devices That Minimize Hospital Visits
  • Rising Use of AI in Healthcare Expands Market for Connected Devices with Predictive Analytics and Personalized Care Features
  • Increasing Need for Continuous Glucose Monitoring Expands Market for Connected Drug Delivery Devices in Diabetes Management
  • Growing Focus on Remote Clinical Trials Drives Demand for Connected Drug Delivery Devices That Enable Real-Time Data Collection
  • Rising Investment in Smart Inhalers and Connected Injectors Propels Growth in Asthma and Respiratory Disease Management
  • Increasing Adoption of Wearable Health Tech Expands Applications of Connected Drug Delivery Devices in Chronic Disease Management
  • Growth in Preventive Healthcare Expands Market for Connected Devices That Monitor Patient Metrics and Predict Health Risks
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Standalone Components & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Standalone Components & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Integrated Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Integrated Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Inhalational Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Inhalational Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Diabetes Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Diabetes Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Connected Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 18: World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 20: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 21: USA 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 22: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 23: USA 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 24: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 25: USA 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 28: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: Canada 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 30: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Canada 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
JAPAN
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 32: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Japan 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 34: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Japan 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Japan 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
CHINA
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 40: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: China 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 42: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 43: China 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
EUROPE
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 44: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 46: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: Europe 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 48: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: Europe 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 51: Europe 7-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
FRANCE
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 52: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: France 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 54: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: France 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 56: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
GERMANY
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 58: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Germany 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 60: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: Germany 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 62: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
ITALY
  • Table 64: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Italy 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 66: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Italy 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 68: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
UNITED KINGDOM
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 70: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: UK 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 72: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: UK 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 74: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
REST OF EUROPE
  • Table 76: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 77: Rest of Europe 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 78: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 79: Rest of Europe 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Rest of Europe 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
ASIA-PACIFIC
  • Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 82: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 83: Asia-Pacific 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 85: Asia-Pacific 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Asia-Pacific 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
REST OF WORLD
  • Table 88: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 89: Rest of World 7-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2024 & 2030
  • Table 90: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 91: Rest of World 7-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2024 & 2030
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of World 7-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.

Table Information